SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trillium Therapeutics
TRIL 20.74+1.0%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bladerunner17 who wrote (264)2/22/2019 3:02:35 PM
From: scaram(o)uche1 Recommendation

Recommended By
Steve Lokness

   of 294
 
Wasn't aware that it is. Haven't submitted a contest entry with any effort behind picks in at least a decade, as I've mentioned elsewhere. Only participate to participate. Nothing felt better than contributing to Master Gardeners a few years back, and continue to write modest checks for EBCF and a few of the old winners.

Why would I have picked tril? Looking at my 12/31/18 crystal ball, perhaps I thought that Nic would have grown tired of destroying shareholder value. He could have gotten 3xMC without blinking an eye. 621 has potential applications beyond cancer, wound healing being one. Company would also have made a decent reverse merge candidate.

Just picked at last minute, reviewing bone pile shares.... most likely explanation, but don't have one. Can probably only name two of my 2019 portfolio components.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News